Salinda, Felix B.

HRN: 21-40-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFTAZIDIME 1GM (VIAL)
05/27/2022
06/02/2022
IV
1g
Q8H
CAP-MR
Waiting Final Action 
05/31/2022
CEFUROXIME 1.5GM (VIAL)
05/31/2022
06/07/2022
IV
1.5gram
Q8hrs
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: